key: cord-1053797-d2sebe5q
authors: Barnes, C. Lowry; Zhang, Xiaoran; Stronach, Benjamin; Haas, Derek A.
title: The Initial Impact of COVID-19 on Total Hip and Knee Arthroplasty
date: 2021-01-13
journal: J Arthroplasty
DOI: 10.1016/j.arth.2021.01.010
sha: f775df828714afdfc40f435121d4af7a2a2799d4
doc_id: 1053797
cord_uid: d2sebe5q

BACKGROUND: The SARS-CoV-2 (COVID-19) pandemic caused a massive disruption in elective arthroplasty practice in the United States that to date hasn’t been quantified. We sought to determine the impact of COVID-19 on arthroplasty volumes in the United States, how this varied across the country, andthe resultant financial implications. METHODS: We conducted a retrospective analysis of Medicare fee-for-service beneficiaries undergoing primary and revision total knee arthroplasty (TKA) and total hip arthroplasty (THA) from January 1(st) through March 31(st) 2020 with 74,080 TKAs and 54,975 THAs identified. We calculated the percent drop in average daily cases from before and after March 18,2020. We then examined variation across states in arthroplasty case volumes as it related to reported COVID-19 cases, the impact of COVID-19 on length of stay (LOS) and percentage of patients discharged home. Finally, we calculated the revenue impact on hospitals and surgeons. RESULTS: There was a steep decline in TKA and THA volumes in mid-March of 94% and 92% respectively. There was a significant variation for arthroplasty case volumes across states. We found minimal change in LOS except for primary THAs with fracture going from 5+ days to 4 days. We saw an increasing trend in discharge to home with the greatest effect in primary THAs with fracture. The total daily hospital Medicare revenue for arthroplasty declined by 87% and surgeon revenue decreased by 85%. CONCLUSION: The beginning of the COVID-19 pandemic caused a significant decrease in arthroplasty volumes in the Medicare population with a resultant substantial revenue loss for hospitals and surgeons.

Background 4 5

The SARS-CoV-2 (COVID-19) pandemic caused a massive disruption in elective arthroplasty 6 practice in the United States that to date hasn't been quantified. We sought to determine the impact of There was a steep decline in TKA and THA volumes in mid-March of 94% and 92% respectively. There 23 was a significant variation for arthroplasty case volumes across states. We found minimal change in LOS 24 except for primary THAs with fracture going from 5+ days to 4 days. We saw an increasing trend in 25 discharge to home with the greatest effect in primary THAs with fracture. The total daily hospital 26 Medicare revenue for arthroplasty declined by 87% and surgeon revenue decreased by 85%. 

We first examined the daily trend in the case volume during the first calendar quarter of 2020.

We excluded weekend days since almost all arthroplasties were performed Monday-Friday. We 

We also found surgical volume decreases in essential orthopaedic surgeries, such as THA for femoral 164 neck fracture, and non-orthopaedic surgeries, such as CABG and major bowel procedures, but none as 165 severe as primary total joint arthroplasty. This led to a significant backlog of arthroplasty procedures 166 that needed to be performed and has had lasting effects on the practice of arthroplasty [10, 11] . We did 167 not see a similar dramatic decrease in revision arthroplasty volume. We suspect this is due to many of 168 these surgeries being justifiably deemed essential, such as prosthetic joint infection or recurrent hip 169 dislocation, with further delay placing the patient at risk for increased morbidity.

There have been recent dramatic changes in the field of arthroplasty prior to COVID-19 in 171 regards to reimbursement and clinical care. This has included the removal of total knee arthroplasty (TKA) from the Centers for Medicare and Medicaid Services (CMS) inpatient only (IPO) list and 173 subsequent approval as an Ambulatory Surgery Center (ASC) qualified procedure [12, 13] . CMS also 174 removed total hip arthroplasty (THA) from the IPO list in January, 2020, 3 months prior to pandemic 175 [14] . There continued to be a shift towards short stay and outpatient total joint arthroplasty, which 176 previously has been driven by economics, and is now potentially being further accelerated due to the 177 pandemic. We saw a decrease in LOS during our study timeframe for primary procedures. The onset of 178 COVID also reversed what had been a trend towards more primary non-fracture cases being done on a 179 hospital outpatient basis.

There was a shift in the arthroplasty community away from the use of post-discharge rehab 181 facilities and skilled nursing facilities prior to the advent of the COVID-19 pandemic [15] . We found an 182 acceleration of this process in the Medicare population during our study period with a significant shift 183 towards a discharge to home. This was most dramatic in the hip fracture population. We speculate this 184 is likely due to a desire to avoid skilled nursing facilities during the COVID-19 pandemic to prevent viral 185 exposure. This demonstrates that many of the patients that have previously been sent to these facilities 186 prior to the pandemic can likely be discharged to home if appropriate care can be provided but further 187 analysis of readmissions and complications in this population needs to be undertaken to better 188 understand the consequences of this change in practice.

Arthroplasty has occupied a unique space during the COVID-19 pandemic as it accounts for a 190 significant amount of revenue for the healthcare system but also is viewed as a non-essential procedure (1) A trendline with R square was added to the scatterplot to display the correlation (2) States with an average daily volume smaller than 10 before March 18th were excluded from the scatterplot (3) Percentage change in TKA and THA volumes was calculated by comparing the average daily volume before and after March 18 th for each state 

COVID-19 infection: Origin, transmission, and 222 characteristics of human coronaviruses

CDC Confirms Person-to-Person Spread of New Coronavirus in the United States

The Effect of the 227 COVID-19 Pandemic on Electively Scheduled Hip and Knee Arthroplasty Patients in the United 228

CMS Releases Recommendations 230 on Adult Elective Surgeries, Non-Essential Medical, Surgical, and Dental Procedures During 231 COVID-19 Response

A Review of State 233 Guidelines for Elective Orthopaedic Procedures During the COVID-19 Outbreak

Effect of COVID-19 on Hip and Knee Arthroplasty Surgical

Quantifying the 245 Backlog of Total Hip and Knee Arthroplasty Cases: Predicting the Impact of COVID-19

SARS-CoV-2 Impact on Elective Orthopaedic Surgery: Implications 248 forPost-Pandemic Recovery

Total Knee Arthroplasty in Ambulatory Surgery Centers: 251 The New Reality!

An Examination of the Adoption of Outpatient Total Knee 253

CY 2020 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical

Center Payment System Final Rule (CMS-1717-FC)

Current Trends in Discharge Disposition and Post-discharge Care After Total 260

COVID-postponed joint replacements are costing U.S. health systems around $2

) Weekends were excluded from the plot due to the fact that almost all arthroplasties were performed Monday-Friday (2) Primary TKA and THA procedures were identified usingMS-DRG 469-470 and an ICD-10-PCS code that started with 0SRC, 0SRD, 0SR9 or 0SRB for inpatient cases, and CPT 27447 or 27130 for outpatient cases

Revision TKA and THA procedures were identified using MS-DRG 466-468

Hip fracture cases were identified using ICD-10-CM codes of the primary diagnosis within primary THA procedures 0 500 1000 1500

Revision TKA (3) Primary THA without Fracture (2, 4) Primary THA with Fracture (2, 4) Revision THA (3)

Surgeon General recommends stopping elective surgeries on